Skip to content
South Africa Health Products Regulatory Authority (SAHPRA)
-
South Africa secures first doses of twice-yearly HIV injectable Lenacapavir
The South African Health Products Regulatory Authority officially approved Lenacapavir, branded as Sunlenca, on October 27, 2025, making South Africa the first African country to authorize this innovation.
-
SAHPRA recalls Citro-Soda regular batches due to contamination risk at Johannesburg facility
The recall covers Citro-Soda Regular in 60g, 120g, and 4g sachet sizes — specifically batches whose numbers begin with the letter “C.”